Explore / Clinical trial
Clinical trial

Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214

AstraZenecaWithdrawnPhase 1Started Jan 1, 20120 enrolledNCT01500018

Abstract

This is a single dose, crossover study to assess the abuse potential of TC-5214 compared to placebo, ketamine, and phentermine in healthy recreational polydrug users.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Ketamine

Keywords

Phase Ihealthy recreational polydrug usersabuse liabilityTC-5214Single dose crossover study to evaluate the abuse potential of TC-5214Drug AbuseHealthy

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.